Mehmi I - Search Results

1

Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.

Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R. Atlas E, et al. Among authors: mehmi i. Mol Cancer Res. 2003 Jan;1(3):165-75. Mol Cancer Res. 2003. PMID: 12556556 Free article.

2

Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells.

Salisbury TB, Tomblin JK, Primerano DA, Boskovic G, Fan J, Mehmi I, Fletcher J, Santanam N, Hurn E, Morris GZ, Denvir J. Salisbury TB, et al. Among authors: mehmi i. Biochem Pharmacol. 2014 Oct 1;91(3):390-9. doi: 10.1016/j.bcp.2014.06.015. Epub 2014 Jun 24. Biochem Pharmacol. 2014. PMID: 24971714 Free PMC article.

3

A unique case of chronic myeloid leukemia presenting as monocular vision loss with unilateral retinopathy.

Seraly MP, Gupta SK, Mehmi I, Veltri L, Ghorayeb GR. Seraly MP, et al. Among authors: mehmi i. Am J Ophthalmol Case Rep. 2019 Feb 15;14:67-69. doi: 10.1016/j.ajoc.2019.02.003. eCollection 2019 Jun. Am J Ophthalmol Case Rep. 2019. PMID: 30911698 Free PMC article.

4

Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.

Richardson DR, Ellis B, Mehmi I, Leys M. Richardson DR, et al. Among authors: mehmi i. Int J Ophthalmol. 2017 Jul 18;10(7):1183-1186. doi: 10.18240/ijo.2017.07.28. eCollection 2017. Int J Ophthalmol. 2017. PMID: 28730129 Free PMC article. No abstract available.

5

Metastatic Sarcomatoid Carcinoma of the Small Intestine: a Case Report of Rare Tumor with Literature Review.

Khelfa Y, Alsharedi M, Mehmi I, Raufi A, Arrington A, Lebowicz Y, Pacioles T. Khelfa Y, et al. Among authors: mehmi i. J Gastrointest Cancer. 2016 Dec;47(4):478-481. doi: 10.1007/s12029-015-9778-0. J Gastrointest Cancer. 2016. PMID: 26545611 Review. No abstract available.

6

Expression and regulation of Cyr61 in human breast cancer cell lines.

Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R. Tsai MS, et al. Among authors: mehmi i. Oncogene. 2002 Jan 31;21(6):964-73. doi: 10.1038/sj.onc.1205131. Oncogene. 2002. PMID: 11840342

7

Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.

Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R. Tsai MS, et al. Among authors: mehmi i. Oncogene. 2003 Feb 6;22(5):761-8. doi: 10.1038/sj.onc.1206130. Oncogene. 2003. PMID: 12569369

8

A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.

Atlas E, Bojanowski K, Mehmi I, Lupu R. Atlas E, et al. Among authors: mehmi i. Oncogene. 2003 May 29;22(22):3441-51. doi: 10.1038/sj.onc.1206410. Oncogene. 2003. PMID: 12776196

9

The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

Menéndez JA, Mehmi I, Griggs DW, Lupu R. Menéndez JA, et al. Among authors: mehmi i. Endocr Relat Cancer. 2003 Jun;10(2):141-52. doi: 10.1677/erc.0.0100141. Endocr Relat Cancer. 2003. PMID: 12790776 Review.

10

Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth.

Lupu R, Mehmi I, Atlas E, Tsai MS, Pisha E, Oketch-Rabah HA, Nuntanakorn P, Kennelly EJ, Kronenberg F. Lupu R, et al. Among authors: mehmi i. Int J Oncol. 2003 Nov;23(5):1407-12. doi: 10.3892/ijo.23.5.1407. Int J Oncol. 2003. PMID: 14532983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters